top of page

FDA guidelines on Continuous Manufacturing

Wednesday, February 27th, 2019 - General News

On the 28th of February, FDA Commissioner Scott Gottlieb, and Janet Woodcock, director of the Center for Drug Evaluation and Research, released a statement on the FDA’s modern approach to advanced pharmaceutical manufacturing (you can find the full statement here). The FDA issued a draft guidance to industry to help further support the development and implementation of continuous manufacturing for branded, generic, and over-the-counter drugs. After a thorough analysis of the draft guidance to industry, we are confident that CONTINUUS’ technology and quality strategy are aligned with this document.

Recent Posts

See All

CONTINUUS ON SHOW AT CHPI 2022

Monday, September 26th, 2022 - General News CPHI 2022 is just around the corner and CONTINUUS is pleased to be part of it! From November...

Comments


Contact Us

25 Olympia Ave, Woburn,

MA 01801, USA

  • LinkedIn
  • Youtube
  • Twitter
bottom of page